From Stellar Winds to Solar Power: Science Unveils New Frontiers in Climate, Life, and the Cosmos

Biology & Medicine

• A long-running study analyzing data from three major cohorts—the Health Professionals Follow-up Study, the Nurses' Health Study, and the Nurses' Health Study II—found that optimal weekly strength training for reducing all-cause mortality is between 90–120 minutes [20]. Specifically, participants who performed 90-119 minutes of strength training per week had a 13% lower risk of death from any cause, with no additional reduction in risk observed above 120 minutes [20]. This optimal range was also associated with a 19% lower risk of cardiovascular disease and a 27% lower risk of neurological disease [20]. ^[20]
• An innovative procedure has helped over 50 people suffering from cardioinhibitory syncope, a rare condition where overactive nerve signals cause the heart to stop beating in response to subconscious bodily processes like swallowing [14]. For instance, one patient experienced her heart stopping up to 12 times daily due to swallowing food [14]. This procedure offers a way to tackle the root of this dangerous fainting disorder, transforming patients' lives [14]. ^[14]
• Researchers at ETH Zurich have identified G protein-coupled receptor kinase 2 (GRK2) as a new molecular target implicated in Alzheimer's disease, finding that an abnormal form of this enzyme aggregates and impairs mitochondrial function in both mouse models and human brain tissue samples [2]. The inactive GRK2 promotes amyloid-beta production and clumping, which blocks mitochondria pores, leading to cellular stress and exacerbating the condition [2]. To counteract this damaging cycle, the team developed Compound 10, a chemical compound that successfully prevented abnormal GRK2 from aggregating in tests on mice and human cells, thereby improving mitochondrial function and reducing amyloid-beta accumulation [2]. ^[2]